Antigen Tumor Embryospecific

Tumor embryospecific antigen (A.T.E.S.) is a unique protein that appears in the body only during the embryonic stage of development and then disappears after birth. However, in some types of tumors, it can reappear, which makes it possible to use it for diagnosing and treating cancer.

A.O.E.S. is one of several antigens that are used in cancer immunotherapy. It has high specificity and sensitivity for certain types of cancer, making it a valuable tool for diagnosis and therapy.

In order to detect A.O.E.S., various methods are used, including immunohistochemistry, immunofluorescence and others. These methods make it possible to determine the presence of antigen in tumor tissues and estimate its quantity.

Cancer therapy using A.O.E.S. can be carried out using monoclonal antibodies that bind to the antigen and cause its destruction. This leads to a reduction in the tumor and an improvement in the general condition of the patient.

Overall, A.O.E.S. is an important tool in the diagnosis and treatment of cancer, which allows you to more accurately determine the type of tumor and choose the most effective treatment method.

Introduction

Tumor embitospecific antigen (OESP antigens) are a special type of antigens that are associated with the development of the body and tumors. They differ from other types of antigens in their specificity and appear only under certain conditions. In the article we will look at the history of the discovery of the OESP antigen, its features and application in medicine.

History of the discovery of tumor embryo-specific antigen

OE SP antigens were first described in 1957 by the French scientist Jean Burget. He discovered that some patients with breast cancer had specific antigens in their blood that appeared only during pregnancy